Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucy J Holt

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 14, 2012
Methods for determining the PK parameters of AlbudAbs™ and of long serum half-life drugs made using the AlbudAb™ technologyDaniel Rycroft, Lucy J Holt
Analytical Biochemistry|March 26, 2003
Use of phage display and high-density screening for the isolation of an antibody against the 51-kDa subunit of complex IJohn L Rubinstein, Lucy J Holt, John E Walker, et al.
Trends in Biotechnology|October 24, 2003
Domain antibodies: proteins for therapyLucy J Holt, Chris Herring, Laurent S Jespers, et al.
Protein Engineering, Design & Selection : PEDS|April 5, 2008
Anti-serum albumin domain antibodies for extending the half-lives of short lived drugsLucy J Holt, Amrik Basran, Kate Jones, et al.
Protein Engineering, Design & Selection : PEDS|January 23, 2010
Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferonAdam Walker, Gráinne Dunlevy, Daniel Rycroft, et al.
Basic & Clinical Pharmacology & Toxicology|March 23, 2019
Apelin peptides linked to anti-serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivoCai Read, Peiran Yang, Rhoda E Kuc, et al.
Cardiovascular Diabetology|October 16, 2013
Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the ratWeike Bao, Lucy J Holt, Rob D Prince, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|August 14, 2012
Methods for determining the PK parameters of AlbudAbs™ and of long serum half-life drugs made using the AlbudAb™ technologyDaniel Rycroft, Lucy J Holt
Analytical Biochemistry|March 26, 2003
Use of phage display and high-density screening for the isolation of an antibody against the 51-kDa subunit of complex IJohn L Rubinstein, Lucy J Holt, John E Walker, et al.
Trends in Biotechnology|October 24, 2003
Domain antibodies: proteins for therapyLucy J Holt, Chris Herring, Laurent S Jespers, et al.
Protein Engineering, Design & Selection : PEDS|April 5, 2008
Anti-serum albumin domain antibodies for extending the half-lives of short lived drugsLucy J Holt, Amrik Basran, Kate Jones, et al.
Protein Engineering, Design & Selection : PEDS|January 23, 2010
Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferonAdam Walker, Gráinne Dunlevy, Daniel Rycroft, et al.
Basic & Clinical Pharmacology & Toxicology|March 23, 2019
Apelin peptides linked to anti-serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivoCai Read, Peiran Yang, Rhoda E Kuc, et al.
Cardiovascular Diabetology|October 16, 2013
Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the ratWeike Bao, Lucy J Holt, Rob D Prince, et al.
Pageof 1